In the complex landscape of pharmaceutical manufacturing, the quality and availability of key intermediates are paramount. Among these, Deferasirox stands out as a critical component in the treatment of iron overload disorders. This article delves into the significance of Deferasirox (CAS: 201530-41-8), its chemical properties, and its indispensable role as a pharmaceutical intermediate for manufacturers and formulators worldwide. Understanding the sourcing and application of such compounds is crucial for developing effective therapeutic solutions.

Deferasirox, identified by its CAS number 201530-41-8, is primarily recognized for its function as an oral iron chelator. Its core therapeutic application lies in reducing chronic iron overload in patients who require frequent blood transfusions, a common scenario for individuals with conditions such as beta-thalassemia and other anemias. The drug works by binding to excess iron in the body, facilitating its removal through the kidneys. This mechanism is vital for preventing organ damage that can result from prolonged iron accumulation.

From a chemical perspective, Deferasirox presents as a white or pale yellow powder. Its molecular formula is C21H15N3O4, with a molecular weight of 373.362 g/mol. The compound exhibits a melting point in the range of 260-262°C, indicative of its stable crystalline structure. These physical and chemical characteristics are essential considerations for pharmaceutical manufacturers when integrating Deferasirox into their production processes. High purity, typically 97% min, is a standard requirement to ensure the safety and efficacy of the final medicinal product.

As a pharmaceutical intermediate, Deferasirox is supplied in various packaging sizes, from laboratory quantities like 25g and 100g to bulk packaging for large-scale manufacturing. This flexibility in supply allows companies to procure the exact amounts needed, optimizing inventory and production planning. The availability of reliable suppliers who can consistently deliver high-quality Deferasirox is a cornerstone for pharmaceutical companies operating in the hematology and transfusion medicine sectors.

The importance of sourcing Deferasirox from reputable manufacturers cannot be overstated. A consistent supply chain, coupled with stringent quality control measures, ensures that the intermediate meets all necessary regulatory and pharmaceutical standards. Companies seeking to buy Deferasirox should prioritize suppliers who demonstrate transparency in their manufacturing processes and provide comprehensive documentation, including certificates of analysis. Partnering with a trusted manufacturer offers peace of mind, knowing that the integrity of the end product will not be compromised.

In summary, Deferasirox (CAS 201530-41-8) is a critical pharmaceutical intermediate with significant therapeutic value. Its role in managing iron overload makes it indispensable for treating numerous blood disorders. For pharmaceutical businesses looking to procure this vital compound, understanding its specifications, applications, and the importance of reliable sourcing is key to successful product development and patient care. We aim to be your trusted partner, offering high-quality Deferasirox to meet your manufacturing needs and supporting your mission to improve patient outcomes.